This section presents medications that are known to potentially lead to 'Meningitis cryptococcal' as a side effect. It's important to note that mild side effects are quite common with medications.
ABOUT 500 cases of human infection due to Cryptococcus neoformans have been described since Busse and Buschke separately presented descriptions of clinical findings in the same patient. In addition ...
With Gift Aid, your generous donation of £10 would be worth £12.50 at no extra cost to you. Yes, I want to Gift Aid any donations made to NAM now, in the future and in the past four years I am a UK ...
Cryptococcus neoformans commonly causes opportunistic infection in immunocompromised patients, especially in patients with AIDS. The CD4+ T-lymphocyte count is measured in patients with HIV infection, ...
A: An internist or infectious diseases specialist will treat cryptococcal meningitis. A: Cryptococcal paradoxical IRIS (immune reconstitution inflammatory syndrome) is a complication that arises after ...
-The PLATFORM-CM trial is evaluating oteseconazole and other investigational products against the standard of care for treating cryptococcal meningitis "We are excited to initiate this important study ...
Cryptococcal meningitis, the second-leading cause of HIV-related deaths, is expected to rise as access to care weakens and advanced HIV disease (previously called AIDS) increases. A new, ...
After entering the host, the leading cause of fungal meningitis, Cryptococcus neoformans, rapidly adapts by shrinking in size and acquiring other characteristics that allow it to better infect the ...
Cryptococcal meningitis is the second-biggest killer of people living with HIV after tuberculosis. Now, a global initiative aims to get the gold-standard drug to treat cryptococcal meningitis, ...
International HIV experts have reported approximately 250,000 fungal meningitis cases annually, in the AIDS report, sub-Saharan Africa contributing 73% of cases. This photomicrograph depicts ...
A new, easier-to-administer and patient-friendly sustained-release formulation of flucytosine, a medicine used to treat cryptococcal meningitis, has entered Phase II clinical trials in Malawi and ...
Scientists have captured video footage of meningitis as it spreads through a brain. Experts used transparent fish to watch in real-time as Cryptococcal meningitis spread through the organ. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback